De patienter, som fik Zevalin som konsoliderende behandling, overlevede længere uden at sygdommen forværredes end de patienter, som ingen supplerende behandling fik.
When Zevalin was used as consolidation therapy, patients survived for longer without their disease getting worse than when they received no further treatment.